The Medicines for Human Use (Clinical Trials) Regulations 2004 No. 1031

SCHEDULE 3 PARTICULARS AND DOCUMENTS THAT MUST ACCOMPANY AN APPLICATION FOR AN ETHICS COMMITTEE OPINION, A REQUEST FOR AUTHORISATION, A NOTICE OF AMENDMENT AND A NOTIFICATION OF THE CONCLUSION OF A TRIAL

PART 2 REQUEST FOR AUTHORISATION

6.  A description of any investigational medicinal product to be used in the trial.